[
    {
        "file_name": "RevolutionMedicinesInc_20200117_S-1_EX-10.1_11948417_EX-10.1_DevelopmentAgreement.txt",
        "perturbation": [
            {
                "type": "Omissions - Omission Legal Contradiction",
                "original_text": "Each Party shall procure and maintain insurance, including product liability insurance, with respect to its activities hereunder and under the Ancillary Agreements and which is consistent with normal business practices of companies similarly situated at all times during which any SHP2 Inhibitors or Product is being clinically tested in human subjects or commercially distributed or sold. Sanofi may fulfill such obligation through self- insurance. Each Party shall provide the other Party with evidence of such insurance upon request and, in the case of RevMed, shall provide Sanofi with written notice at least [***] prior to the cancellation, non-renewal or material changes in such insurance.",
                "changed_text": "Each Party shall procure and maintain insurance with respect to its activities hereunder and under the Ancillary Agreements. Sanofi may fulfill such obligation through self- insurance. Each Party shall provide the other Party with evidence of such insurance upon request.",
                "explanation": "By omitting the phrase 'including product liability insurance' and 'which is consistent with normal business practices of companies similarly situated at all times during which any SHP2 Inhibitors or Product is being clinically tested in human subjects or commercially distributed or sold', the contract removes the obligation to maintain adequate and appropriate insurance coverage. Also, it omits providing written notice at least [***] prior to the cancellation, non-renewal or material changes in such insurance",
                "contradicted_law": "General contract law principles requiring reasonable and adequate insurance coverage to protect against foreseeable risks, and specific product liability laws in the relevant jurisdictions.",
                "location": "14.6"
            },
            {
                "type": "Omissions - Omission Legal Contradiction",
                "original_text": "To the Knowledge of RevMed, all Patent Rights owned or Controlled by RevMed, existing as of the Execution Date, and reasonably necessary or useful for conducting the Collaboration or otherwise necessary or useful for Researching, Developing, Manufacturing, Commercializing or otherwise exploiting Product in the Field, including the Development or Manufacture of the Products as contemplated in the initial Research Plan and Development Plan attached to this Agreement as of the Execution Date and Commercialization of the Products, as provided hereunder are listed in Exhibit O of the Correspondence;",
                "changed_text": "All Patent Rights owned or Controlled by RevMed, existing as of the Execution Date, that are necessary or useful for conducting the Collaboration or otherwise necessary or useful for Researching, Developing, Manufacturing, Commercializing or otherwise exploiting Product in the Field, are listed in Exhibit O of the Correspondence;",
                "explanation": "By removing 'To the Knowledge of RevMed' and 'including the Development or Manufacture of the Products as contemplated in the initial Research Plan and Development Plan attached to this Agreement as of the Execution Date and Commercialization of the Products, as provided hereunder', the contract weakens the warranty, potentially opening RevMed up to liability if any necessary patent rights are not listed in Exhibit O, even if RevMed was unaware of them.",
                "contradicted_law": "Contract law principles relating to the accuracy and completeness of representations and warranties; intellectual property law principles relating to due diligence and disclosure of relevant patent rights.",
                "location": "13.2(d)"
            },
            {
                "type": "Omissions - Omission Legal Contradiction",
                "original_text": "In addition, Sanofi shall have the right to conduct customary reviews and audits of RevMed and its Affiliates and subcontractors (provided that, with respect to Permitted Contractors or Researchers that RevMed entered into a written agreements with prior to the Effective Date, such right of Sanofi shall be to the extent RevMed has the right to permit Sanofi to do so under such written agreements, and provided further, that RevMed shall use Commercially Reasonable Efforts to secure such right for Sanofi where one does not exist).",
                "changed_text": "Sanofi shall have the right to conduct reviews of RevMed and its Affiliates and subcontractors.",
                "explanation": "By removing '(provided that, with respect to Permitted Contractors or Researchers that RevMed entered into a written agreements with prior to the Effective Date, such right of Sanofi shall be to the extent RevMed has the right to permit Sanofi to do so under such written agreements, and provided further, that RevMed shall use Commercially Reasonable Efforts to secure such right for Sanofi where one does not exist)', Sanofi's right to review and audit is strengthened, increasing RevMed's compliance burden and potential liability for breaches by its subcontractors.",
                "contradicted_law": "Privacy laws protecting confidential information and limiting audits. Without this, Sanofi could demand more audit rights than are allowed under law.",
                "location": "6.9"
            }
        ]
    }
]